US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 10.920
  • -0.130-1.18%
Trading Jan 23 11:07 ET
720.40MMarket Cap-9.58P/E (TTM)

Fulcrum Therapeutics (FULC) Revenue Breakdown Overview

By Business/Source

Currency:USD
2024/FY
Stock NameRevenueRatio
Developing small molecules to improve the lives of patients with genetically defined rare diseases80M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States80M100.00%
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More